Mycobacterium bovis BCG live attenuated vaccine (Bandim Health Project)

N/A

Report date: 2024/12/11 10:09:25

Base Information

Drug NameMycobacterium bovis BCG live attenuated vaccine (Bandim Health Project)
Drug Alias NameBCG (SSI strain)BCG Vaccine SSIBCG-Denmark-1331BCG-1331BCG-AJ +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Tuberculosis, PulmonaryTuberculosis
Global Approved IndicationsTuberculosis, Pulmonary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryDenmark
Original Approved Date1987/01/01
Country/TerritorySouth AfricaDenmark
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBandim Health Project
China Registration ClassN/A

Develop Information

Active CompaniesBandim Health Project
Inactive CompaniesBill & Melinda Gates Medical Research Institute
Active IndicationsCoronavirus Disease 2019 (COVID-19)Tuberculosis, Pulmonary
Inactive IndicationsTuberculosis

Other Information

ATC CodeL03AX03
Related LinksN/A